» Articles » PMID: 8940040

Cyclic AMP Induces Apolipoprotein E Binding Activity and Promotes Cholesterol Efflux from a Macrophage Cell Line to Apolipoprotein Acceptors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 Nov 29
PMID 8940040
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

RAW 264 mouse macrophage cells were stably transfected with human apolipoprotein E (apoE) expression vectors. Clonal derivatives were characterized for expression of the human apoE2, apoE3, and apoE4 isoforms. An apoE4-expressing clonal cell line and a non-expressing clonal control cell line were loaded overnight with either [3H]cholesterol or [3H]choline. The cells were washed and incubated for 24 h in serum-free medium with or without the addition of 8-bromo-cyclic AMP (8-Br-cAMP). Only the apoE-secreting cells and only in the presence of 8-Br-cAMP released large amounts of labeled cholesterol or phosphatidylcholine into the medium. Mass analyses of cellular free and esterified cholesterol confirmed the results of the labeling studies; a decrease in cellular cholesterol content was observed in the 8-Br-cAMP-treated apoE-secreting cells, concurrent with an increase in cholesterol found in the medium. FPLC analysis of the medium demonstrated that 8-Br-cAMP treatment of the apoE-secreting cells led to an increased size fraction and amount of a peak of secreted cholesterol which comigrated with apoE. The 8-Br-cAMP-mediated increase in cholesterol efflux was also observed in non-apoE-secreting cells incubated with exogenous apoE or apoAI, and the effect of apoE was saturable. The apoE2, apoE3, and apoE4 isoforms were equally efficient in promoting 8-Br-cAMP-dependent cholesterol efflux. Reductive methylation of apoE abolished its ability to promote 8-Br-cAMP-dependent cholesterol efflux. Brefeldin A and monensin, inhibitors of protein processing through the Golgi, both blocked the 8-Br-cAMP stimulation of cholesterol efflux to exogenous apoE. 8-Br-cAMP induced specific apoE and apoAI binding, but not apoE degradation, by the RAW cells. We present a model wherein cAMP induces a membrane apolipoprotein receptor that does not lead to endocytosis and degradation, but instead promotes the transfer of lipids to apolipoproteins, which can then be released from the cell.

Citing Articles

Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis.

Iyer D, Venkatraman J, Tanguy E, Vitale N, Mahapatra N Cell Mol Life Sci. 2023; 80(9):271.

PMID: 37642733 PMC: 11072126. DOI: 10.1007/s00018-023-04908-3.


Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells.

Komatsu T, Abe S, Nakashima S, Sasaki K, Higaki Y, Saku K Biomolecules. 2023; 13(2).

PMID: 36830597 PMC: 9953524. DOI: 10.3390/biom13020228.


Rapid degradation of ABCA1 protein following cAMP withdrawal and treatment with PKA inhibitor suggests ABCA1 is a short-lived protein primarily regulated at the transcriptional level.

Srivastava N, Cefalu A, Averna M, Srivastava R J Diabetes Metab Disord. 2020; 19(1):363-371.

PMID: 32550187 PMC: 7271302. DOI: 10.1007/s40200-020-00517-0.


Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Litvinov D, Savushkin E, Dergunov A Pharmaceut Med. 2020; 33(6):465-498.

PMID: 31933239 PMC: 7101889. DOI: 10.1007/s40290-019-00308-w.


StarD5: an ER stress protein regulates plasma membrane and intracellular cholesterol homeostasis.

Rodriguez-Agudo D, Malacrida L, Kakiyama G, Sparrer T, Fortes C, Maceyka M J Lipid Res. 2019; 60(6):1087-1098.

PMID: 31015253 PMC: 6547630. DOI: 10.1194/jlr.M091967.